Having trouble accessing articles? Reset your cache.

Iniparib: Final Phase II data

Final data from a Phase II trial in 123 patients showed that BS1-201 plus Gemzar gemcitabine and carboplatin significantly improved median OS vs.

Read the full 232 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE